Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

HIV-1 Resistant CDK2-Knockdown Macrophage-Like Cells Generated from 293T Cell-Derived Human Induced Pluripotent Stem Cells.

Jerebtsova M, Kumari N, Xu M, de Melo GB, Niu X, Jeang KT, Nekhai S.

Biology (Basel). 2012 Jul 26;1(2):175-195.

2.

Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis.

Lachmann N, Happle C, Ackermann M, Lüttge D, Wetzke M, Merkert S, Hetzel M, Kensah G, Jara-Avaca M, Mucci A, Skuljec J, Dittrich AM, Pfaff N, Brennig S, Schambach A, Steinemann D, Göhring G, Cantz T, Martin U, Schwerk N, Hansen G, Moritz T.

Am J Respir Crit Care Med. 2014 Jan 15;189(2):167-82. doi: 10.1164/rccm.201306-1012OC.

PMID:
24279725
3.

Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.

El Khatib MM, Ohmine S, Jacobus EJ, Tonne JM, Morsy SG, Holditch SJ, Schreiber CA, Uetsuka K, Fusaki N, Wigle DA, Terzic A, Kudva YC, Ikeda Y.

Stem Cells Transl Med. 2016 May;5(5):694-702. doi: 10.5966/sctm.2015-0017. Epub 2016 Mar 17.

4.
5.

Self-renewal and pluripotency acquired through somatic reprogramming to human cancer stem cells.

Nagata S, Hirano K, Kanemori M, Sun LT, Tada T.

PLoS One. 2012;7(11):e48699. doi: 10.1371/journal.pone.0048699. Epub 2012 Nov 8.

6.

Reprogramming human endometrial fibroblast into induced pluripotent stem cells.

Chen YJ, Liou YJ, Chang CM, Li HY, Chen CY, Twu NF, Yen MS, Chang YL, Peng CH, Chiou SH, Chen CP, Chao KC.

Taiwan J Obstet Gynecol. 2012 Mar;51(1):35-42. doi: 10.1016/j.tjog.2012.01.008.

7.

Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.

Leng L, Tan Y, Gong F, Hu L, Ouyang Q, Zhao Y, Lu G, Lin G.

Hum Reprod. 2015 Mar;30(3):737-48. doi: 10.1093/humrep/deu358. Epub 2015 Jan 12.

PMID:
25586786
8.

Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells.

Kambal A, Mitchell G, Cary W, Gruenloh W, Jung Y, Kalomoiris S, Nacey C, McGee J, Lindsey M, Fury B, Bauer G, Nolta JA, Anderson JS.

Mol Ther. 2011 Mar;19(3):584-93. doi: 10.1038/mt.2010.269. Epub 2010 Nov 30.

9.

Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.

Tiemann U, Sgodda M, Warlich E, Ballmaier M, Schöler HR, Schambach A, Cantz T.

Cytometry A. 2011 Jun;79(6):426-35. doi: 10.1002/cyto.a.21072. Epub 2011 May 4.

10.

Reprogramming of mouse somatic cells into pluripotent stem-like cells using a combination of small molecules.

Kang PJ, Moon JH, Yoon BS, Hyeon S, Jun EK, Park G, Yun W, Park J, Park M, Kim A, Whang KY, Koh GY, Oh S, You S.

Biomaterials. 2014 Aug;35(26):7336-45. doi: 10.1016/j.biomaterials.2014.05.015. Epub 2014 Jun 2.

PMID:
24881998
11.

HMGA1 reprograms somatic cells into pluripotent stem cells by inducing stem cell transcriptional networks.

Shah SN, Kerr C, Cope L, Zambidis E, Liu C, Hillion J, Belton A, Huso DL, Resar LM.

PLoS One. 2012;7(11):e48533. doi: 10.1371/journal.pone.0048533. Epub 2012 Nov 15.

12.

Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.

Phang RZ, Tay FC, Goh SL, Lau CH, Zhu H, Tan WK, Liang Q, Chen C, Du S, Li Z, Tay JC, Wu C, Zeng J, Fan W, Toh HC, Wang S.

Stem Cells Transl Med. 2013 Dec;2(12):935-45. doi: 10.5966/sctm.2013-0043. Epub 2013 Oct 28.

13.

Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.

Drozd AM, Walczak MP, Piaskowski S, Stoczynska-Fidelus E, Rieske P, Grzela DP.

Stem Cell Res Ther. 2015 Jun 19;6:122. doi: 10.1186/s13287-015-0112-3.

14.

An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation.

Hohenhaus DM, Schaale K, Le Cao KA, Seow V, Iyer A, Fairlie DP, Sweet MJ.

Immunobiology. 2013 Nov;218(11):1345-53. doi: 10.1016/j.imbio.2013.07.001. Epub 2013 Jul 15.

PMID:
23948647
15.

Establishment of transgene-free induced pluripotent stem cells reprogrammed from human stem cells of apical papilla for neural differentiation.

Zou XY, Yang HY, Yu Z, Tan XB, Yan X, Huang GT.

Stem Cell Res Ther. 2012 Oct 24;3(5):43. doi: 10.1186/scrt134.

16.

Emerging methods for preparing iPS cells.

Miyazaki S, Yamamoto H, Miyoshi N, Takahashi H, Suzuki Y, Haraguchi N, Ishii H, Doki Y, Mori M.

Jpn J Clin Oncol. 2012 Sep;42(9):773-9. doi: 10.1093/jjco/hys108. Epub 2012 Jul 23. Review.

PMID:
22826352
17.

Transgene-free iPSCs generated from small volume peripheral blood nonmobilized CD34+ cells.

Merling RK, Sweeney CL, Choi U, De Ravin SS, Myers TG, Otaizo-Carrasquero F, Pan J, Linton G, Chen L, Koontz S, Theobald NL, Malech HL.

Blood. 2013 Apr 4;121(14):e98-107. doi: 10.1182/blood-2012-03-420273. Epub 2013 Feb 5.

19.

Generation of mice derived from induced pluripotent stem cells.

Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Martin G, Kupriyanov S, Baldwin KK.

J Vis Exp. 2012 Nov 29;(69):e4003. doi: 10.3791/4003.

Supplemental Content

Support Center